Acasti Pharma reported $-4829000 in EBITDA for its fiscal quarter ending in September of 2024.


Ebitda Change Date
Acasti Pharma USD -4829000 133K Sep/2024
Addus HomeCare USD 43.93M 9.47M Jun/2025
Amarin USD -16025000 714K Mar/2025
Cassava Sciences USD -45174000 15.95M Jun/2025
Knight Therapeutics CAD 16.72M 1.05M Sep/2024
Option Care Health USD 114.02M 20.86M Jun/2025
Organigram Holdings CAD 2.68M 18.86M Jun/2025
Tilray USD -101000 2.32M Nov/2024